Sector: MedicalCGRB (OTCBB: CGRB)
Headlines
- Johnson & Johnson (NYSE: JNJ) Beat Estimates Yet Again
Jul 14, 2009 12:34 PM | CGRB, ELN, GS, JNJ
- OTC Select Announces Nasdaq Stock Watch
Jun 01, 2009 04:00 PM | AGEN, ANDS, CGRB, DVAX, EPEX
- Access Pharma (OTC: ACCP.OB): A Cancer Biotech Call Option Trade
May 27, 2009 01:05 PM | CGRB, CTIC, DNDN, JNJ, RHHBY, SNY
- J&J (NYSE: JNJ) Beefs Up Oncology Portfolio
May 22, 2009 12:27 PM | CGRB, JNJ
- NASDAQ Technical Picture - Hanging Man to End Bullish Week
May 19, 2008 01:56 AM | ADI, AEA, ANN, ARO, ARUN, ASPM
- J&J posts lower 2Q profit, but still beats view
Jul 14, 2009 01:51 PM | CGRB, ELN, JNJ
- General Motors, McClatchy are big movers
May 22, 2009 05:17 PM | AIG, ARO, CGRB, GM, JNJ, SHLD
- Cougar Biotechnology Announces Successful Completion of Johnson & Johnson’s Initial Tender Offer and Commencement of Subsequent Offering Period
Jul 03, 2009 12:01 PM | CGRB
- Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Jul 03, 2009 08:54 AM | CGRB, JNJ
- Cougar Biotechnology Announces Dismissal of Class Action Complaint Seeking to Enjoin Tender Offer and Termination of Hart-Scott-Rodino Waiting Period
Jun 23, 2009 12:51 PM | CGRB, JNJ
- Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
Jun 17, 2009 05:33 PM | CGRB, JNJ
- CORRECTING and REPLACING Cougar Biotechnology’s Board of Directors Recommends Stockholders Accept Johnson & Johnson’s $43.00 Per Share Cash Tender Offer
Jun 05, 2009 09:41 AM | CGRB, JNJ
- Cougar Biotechnology’s Board of Directors Recommends Stockholders Accept Johnson & Johnson’s $43.00 Per Share Cash Tender Offer
Jun 05, 2009 09:06 AM | CGRB, JNJ
- Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology
Jun 05, 2009 09:02 AM | CGRB, JNJ
- Biotech Shows Glimmer of an Upward Trend
Jun 01, 2009 12:55 PM | AMGN, CGRB, GILD, JNJ
- Cougar Biotechnology Presents Positive CB7630 (Abiraterone Acetate) Phase II Data at ASCO Annual Meeting
May 31, 2009 08:02 AM | CGRB
- Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
May 21, 2009 07:06 PM | CGRB, JNJ
- Form 4 Saks Samuel R For: Jul 03 (10K)
Jul 07, 2009 05:54 PM
- Form 4 Richman Michael For: Jul 03 (10K)
Jul 07, 2009 05:54 PM
- Form 4 PHILLIPS RICHARD BENTON For: Jul 03 (10K)
Jul 07, 2009 05:50 PM
- Form 4 MOLINA ARTURO MD For: Jul 03 (10K)
Jul 07, 2009 05:48 PM
- Form 4 MEYERS HAROLD J For: Jul 03 (10K)
Jul 07, 2009 05:46 PM
- Form 4 Malley Thomas For: Jul 03 (10K)
Jul 07, 2009 05:45 PM
- Form 4 EYLER CHARLES R For: Jul 03 (10K)
Jul 07, 2009 05:43 PM
- Form 4 ELLISON RUSSELL H For: Jul 03 (10K)
Jul 07, 2009 05:40 PM
- Form 4 Belldegrun Arie For: Jul 03 (10K)
Jul 07, 2009 05:37 PM
- Form 4 AUERBACH ALAN H For: Jul 03 (10K)
Jul 07, 2009 05:34 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CGRB
|
Compare to S&P
|
| YTD |
-0.01 %
|
69.96 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -7.69 %
|
|
EPS Growth in Last Year: -261.29 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
